Liver Cancer

CURE’s liver cancer page features the latest cancer news and updates on liver cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in liver cancer.

Latest News

Rivoceranib-Airuika Combo Improves Survival in Liver Cancer Subset

By Ashley Chan

July 20th 2023

Rivoceranib plus Airuika demonstrates improvement for survival in patients with unresectable hepatocellular carcinoma, a subset of liver cancer.

Imfinzi-Imjudo Combo Provides Survival Benefit Over 4 Years in Liver Cancer Subset

By Darlene Dobkowski, MA

July 1st 2023

First Patient Dosed With Novel CAR-M Cell Therapy Plus Keytruda for HER2-Overexpressing Cancer

By Darlene Dobkowski, MA

June 28th 2023

Imjudo-Imfinzi Regimen Improves Survival With Manageable Side Effects in Liver Cancer Subset

By Lindsay Fischer

June 3rd 2023

Foreign-Born Patients With HCC May Have Improved Survival Versus U.S.-Born Patients

By Darlene Dobkowski, MA

May 25th 2023

More News

What a Carcinoid Cancer Diagnosis Means

September 2nd 2016

Why Carcinoid Tumors Might Be Missed

September 2nd 2016

Brenda's Carcinoid Tumor Diagnosis

September 2nd 2016

Living with Carcinoid Tumors

September 2nd 2016

Why You Need an Expert in NETS

September 2nd 2016

A Surgery Story: Pancreatic NETs

September 2nd 2016

Pancreatic NETs: Michael's Story

September 2nd 2016

What Are Neuroendocrine Tumors?

September 2nd 2016

Coffee Not a Carcinogen, But May Still Be Too Hot to Handle

Brielle Urciuoli

June 22nd 2016

After more than two decades, the International Agency for Research on Cancer re-evaluated the carcinogenic of coffee, and looked to the beverage temperature instead.

Stivarga Improves Survival in Phase 3 Liver Cancer Trial

Jason M Broderick

May 9th 2016

Stivarga (regorafenib) proved to have better overall survival for patients with HCC in a recent phase 3 trial.

"Silent" Portal Vein Thrombosis, A Dangerous Side Effect From Cancer

Andrew J. Roth

May 3rd 2016

Nurses and oncologists need to give portal vein thrombosis a closer look, according to one oncolgy nurse.

Novel Agents, Including Immunotherapy, Look to Conquer Advanced Liver Cancer

Silas Inman

April 27th 2016

A number of novel therapies are currently being explored as second-line treatments for patients with advanced hepatocellular carcinoma (HCC), including a host of targeted therapies and various immune checkpoint inhibitors.

American Liver Foundation Seeks to Address Current Issues in Liver Health

Lauren Santye

March 5th 2016

There are currently 30 million Americans with some form of liver disease. Through education and advocacy, the American Liver Foundation wants to decrease that number.